Diabetes Mellitus, Type II
Conditions
Keywords
Diabetes
Brief summary
A treatment with the concept of mitochondrial medication developed by Dr Heinrich Kremer can demonstrably improve and successfully treat actual parameters of Diabetes Mellitus II as well as its risk factors.
Interventions
DIETARY_SUPPLEMENTMitochondrial preparations
Oral therapy with mitochondrial preparations based on recipes of Dr Kremer and the Tisso company: ProEMSan (large intestinal symbionts with 31 strains of bacteria) Pro Basan (small intestinal symbionts) ProSirtusan (Polyphenol-mix and vitamins) ProVita D3 (Vitamin D3 supplement) ProOmega (Omega 3-fatty acid preparation) ProCarnitin (Carnitine-preparation) ProSango Vital (trace element preparation)
DIETARY_SUPPLEMENTInfusion therapy
Infusion therapy in the form of a complex mix: 500ml-solution with trace elements, amino acids and antioxidants.
DEVICEWebermedical device
Intravenous-Blood-Laser-Therapy: the Webermedical device will be used
BEHAVIORALNutritional therapy
Nutritional therapy based on IgG-blood results. Significant antibody-formation against foodstuffs will be ascertained (in foodstuffs evaluated through the BioMedicalScreen), will be taken out of the diet - the background being the additional lowering of risk potential of those antibodies causing the so called silent inflammation (sub-clinical inflammation) -ultimately an anti-inflammatory diet will be given in the protocol. The following have special focus: gluten, cow's milk, fish, meat, nuts.
Sponsors
Center for Integrative Medicine, Germany
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
* men and women between the ages of 18 and 60 * recently diagnosed Diabetes Type II (within the last 12 months)
Exclusion criteria
* no orally-taken medication up to present * no insulin therapy * no diseases resulting from diabetes like Nephropathy, Neuropathy, Angiopathy or Retinopathy * fasting blood sugar values in the morning under 200mmol * sufficient production of insulin
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| HbA1c Test (Glycated hemoglobin) | 4 month average | Laboratory test |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Electrolytes | 4 month average | Laboratory test |
| Liver, pancreatic and kidney retention values | 4 month average | Laboratory test |
| Lipids: Cholesterol,Triglycerides | 4 month average | Laboratory test |
| Oxyd LDL (low-density lipoprotein cholesterol) | 4 month average | Laboratory test |
| Free lipids fasting | 4 month average | Laboratory test |
| Lipoprotein A | 4 month average | Laboratory test |
| Fibrinogen | 4 month average | Laboratory test |
| CRP (C Reactive protein) | 4 month average | Laboratory test |
| Blood count | 4 month average | Laboratory test |
| Homocysteins | 4 month average | Laboratory test |
| Nutrient IgGs Panels (BiomedicalScreen) | 4 month average | Laboratory test |
| Insulin, Adiponectin, Leptin | 4 month average | Laboratory test |
| Potassium, selene, magnesium, zinc in whole blood | 4 month average | Laboratory test |
| SHbG, full-testosterone (Androgen-Index) | 4 month average | Laboratory test |
| PlasminInhibitor I | 4 month average | Laboratory test |
| Vitamins B1,B2,B6,B 12, Vitamin D | 4 month average | Laboratory test |
| LDH-Isoenzymes (Lactate dehydrogenase) | 4 month average | Laboratory test |
Countries
Germany
Contacts
Primary ContactRainer Mutschler, MD
Outcome results
None listed